You are correct and I’m happy to discount. The older of the two patients in the original example was under 50. That’s a lot of QALYs. Even at an implausibly high discount rate it makes sense.

The outcomes reported in the article are suggestive of a large decrease in mortality due to heart attack. Even assuming the effect is much smaller than reported, more widespread use of ecmo machines makes a lot of sense.